U.S. FDA PMA Approval For Paradigm Spine’s Coflex® Interlaminar Technology:



Paradigm Spine Announces U.S. FDA PMA Approval Of Its Landmark Coflex® Interlaminar Technology: (via PR Newswire)

NEW YORK, Oct. 17, 2012 /PRNewswire/ — Paradigm Spine LLC, a provider of innovative spinal implant technologies, announces the U.S. Food and Drug Administration (“FDA”) has granted a Premarket Approval (“PMA”) Order for coflex®, a minimally invasive, Motion Preserving Interlaminar Stabilization™…